Globitair

(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

Yonhap EnglishSouth Korea

(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...

Read the full story at Yonhap EnglishOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about South Korea